Nanosonics Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 311
Employees
  • Stock Symbol
  • NAN
Stock Symbol
  • Share Price
  • $4.39
  • (As of Wednesday Closing)

Nanosonics General Information

Description

Nanosonics is a single-product company and its trophon device provides high-level disinfection, or HLD, of ultrasound probes used in semi-critical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being adopted as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At December 2020, there were 25,100 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 55% in the United States to low-single-digit penetration in EMEA and elsewhere in Asia-Pacific.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Stock Exchange
ASX
Primary Office
  • 14 Mars Road
  • Lane Cove
  • Sydney, New South Wales 2015
  • Australia
+61 (02) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanosonics Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.39 $4.37 $3.51 - $6.36 $1.32B 301M 700K $0.01

Nanosonics Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 1,792,667 1,347,404 1,130,643 643,779
Revenue 65,353 67,468 60,480 46,979
EBITDA 6,456 10,424 12,614 4,540
Net Income 4,051 6,790 9,726 4,455
Total Assets 115,549 101,055 90,709 80,203
Total Debt 1,593 1,793 365 695
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nanosonics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanosonics‘s full profile, request access.

Request a free trial

Nanosonics Executive Team (14)

Name Title Board Seat Contact Info
Ronald Bacskai President & Chief Executive Officer, US
Michael Kavanagh Chief Executive Officer, President & Board Member
David Morris Chief Strategy Officer & Regional President Asia Pacific
McGregor Grant Chief Financial Officer & Company Secretary
Rod Lopez Chief Operating Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Nanosonics Board Members (5)

Name Representing Role Since
00000 000000 00.0 Self Board Member 000 0000
000000 00000 Self Chairman 000 0000
0000000 00000000 Nanosonics Chief Executive Officer, President & Board Member 000 0000
00000 0000000 Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Nanosonics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial